Excess Zinc in Muscles May Drive Cancer-Related Wasting

Share this content:
Excess Zinc in Muscles May Drive Cancer-Related Wasting
Excess Zinc in Muscles May Drive Cancer-Related Wasting

TUESDAY, Aug. 7, 2018 (HealthDay News) -- ZRT- and IRT-like protein 14 (ZIP14) upregulation in skeletal muscles may play a role in cancer-related muscle loss, according to a study published online June 6 in Nature Medicine.

Gang Wang, Ph.D., from Columbia University in New York City, and colleagues explored the underlying mechanisms for cachexia (severe loss of skeletal muscle mass and function in metastatic cancer patients), including use of an animal model.

The researchers found that metal-ion transporter ZIP14 is a critical mediator of cancer-induced cachexia. In cachectic muscles of mice and in patients with metastatic cancer, ZIP14 is upregulated and can be induced by tumor necrosis factor (TNF)-α and TGF-β cytokines. There is marked reduction in muscle atrophy in metastatic cancer models with germline ablation or muscle-specific depletion of Zip14. ZIP14-mediated zinc uptake in muscle progenitor cells represses the expression of MyoD and Mef2c and blocks muscle-cell differentiation. In differentiated muscle cells, ZIP14-mediated zinc accumulation induces myosin heavy chain loss.

"These results highlight a previously unrecognized role for altered zinc homeostasis in metastatic cancer-induced muscle wasting and implicate ZIP14 as a therapeutic target for its treatment," the authors write.

Abstract/ Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: U.S. Abortion Rate Declined 24 Percent From 2006 to 2015

CDC: U.S. Abortion Rate Declined 24 Percent From ...

Abortions among women ages 15-44 fell 26 percent, from 15.9 to 11.8 abortions per 1,000 women

U of Maryland Student Dies of Adenovirus-Related Illness

U of Maryland Student Dies of Adenovirus-Related Illness

CDC testing of specimen revealed adenovirus type 7, a strain that may cause more severe illness

FDA Approves Drug to Treat Rare Immune Disease

FDA Approves Drug to Treat Rare Immune Disease

Gamifant first drug to be approved specifically for primary hemophagocytic lymphohistiocytosis

is free, fast, and customized just for you!




Already a member?

Sign In Now »